Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STERIS plc Director's Dealing 2022

Jun 3, 2022

30229_dirs_2022-06-03_0ea39873-1bb5-4d1e-a255-fe75ca6621ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2022-06-01

Reporting Person: Fraser Mary Clare (SVP & Chief HRO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-06-01 Ordinary Shares F 235 $221.46 Disposed 5223 Direct
2022-06-02 Ordinary Shares A 2028 $0.00 Acquired 7251 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-06-02 Employee Stock Option (right to buy) $250.06 A 9224 Acquired 2032-06-02 Ordinary Shares (9224) Direct

Footnotes

F1: 235 shares were withheld from the 791 restricted shares that vested on June 1, 2022. These 235 shares represent the value of the taxes required
to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 791 ordinary shares were awarded to Ms.
Fraser on August 4, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022.

F2: As of June 2, 2022, 6,138 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025; 692 on October 1, 2025 and 2,028 on June 2, 2026.

F3: This option becomes exercisable as follows: 2,306 on June 2, 2023, 2,306 on June 3, 2024, 2,306 on June 2, 2025 and 2,306 on June 2, 2026.